-
公开(公告)号:US20210139998A1
公开(公告)日:2021-05-13
申请号:US17152529
申请日:2021-01-19
Applicant: GUARDANT HEALTH, INC.
Inventor: AmirAli TALASAZ
IPC: C12Q1/6886 , G16B30/00 , C12Q1/6806 , C12N15/10 , C12Q1/6869 , C12Q1/6874
Abstract: The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
-
公开(公告)号:US20200087736A1
公开(公告)日:2020-03-19
申请号:US16593633
申请日:2019-10-04
Applicant: GUARDANT HEALTH, INC.
Inventor: AmirAli TALASAZ
IPC: C12Q1/6886 , C12Q1/6869 , C12Q1/6806 , C12N15/10 , G16B30/00 , C12Q1/6874
Abstract: The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
-
公开(公告)号:US20190185941A1
公开(公告)日:2019-06-20
申请号:US16283635
申请日:2019-02-22
Applicant: GUARDANT HEALTH, INC.
Inventor: AmirAli TALASAZ
IPC: C12Q1/6886 , G16B30/00 , C12Q1/6806 , C12Q1/6874 , C12N15/10 , C12Q1/6869
CPC classification number: C12Q1/6886 , C12N15/1065 , C12Q1/6806 , C12Q1/6869 , C12Q1/6874 , C12Q2600/118 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16 , G16B30/00 , C12Q2537/165 , C12Q2545/114
Abstract: The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
-
公开(公告)号:US20190085406A1
公开(公告)日:2019-03-21
申请号:US16093916
申请日:2017-04-14
Applicant: GUARDANT HEALTH, INC.
Inventor: Stefanie Ann Ward MORTIMER , AmirAli TALASAZ , Darya CHUDOVA , HELMY ELTOUKHY , Andrew KENNEDY
IPC: C12Q1/6886 , C12M1/34 , G16H50/20 , G16H50/30
Abstract: Disclosed herein are methods, compositions, and devices for use in early detection of cancer. The methods include sequencing a panel of regions in cell-free nucleic acid molecules and detecting one or more tumor markers that are indicative of a cancer.
-
公开(公告)号:US20180327862A1
公开(公告)日:2018-11-15
申请号:US15978848
申请日:2018-05-14
Applicant: GUARDANT HEALTH, INC.
Inventor: AmirAli TALASAZ , HELMY ELTOUKHY
IPC: C12Q1/6886 , C12Q1/6874 , C12Q1/6869 , C12N15/10 , C12Q1/6806 , G06F19/22
CPC classification number: C12Q1/6886 , C12N15/1065 , C12Q1/6806 , C12Q1/6869 , C12Q1/6874 , C12Q2600/118 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16 , G06F19/22 , C12Q2537/165 , C12Q2545/114
Abstract: The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
-
公开(公告)号:US20240345104A1
公开(公告)日:2024-10-17
申请号:US18506573
申请日:2023-11-10
Applicant: GUARDANT HEALTH, INC.
Inventor: AmirAli TALASAZ , Andrew KENNEDY
IPC: G01N33/92 , C12Q1/6886 , G01N33/53 , G01N33/574
CPC classification number: G01N33/92 , C12Q1/6886 , G01N33/5308 , G01N33/57488 , C12Q2600/154 , C12Q2600/156
Abstract: Provided herein are methods of detecting and quantifying target molecules associated with cell debris. Provided herein are also methods for determining the likelihood that a subject has a disease or condition, such as cancer.
-
公开(公告)号:US20240318234A1
公开(公告)日:2024-09-26
申请号:US18677090
申请日:2024-05-29
Applicant: GUARDANT HEALTH, INC.
Inventor: AmirAli TALASAZ , Stefanie Ann Ward MORTIMER
IPC: C12Q1/6827 , C12Q1/6806 , C12Q1/6869 , G16B30/00
CPC classification number: C12Q1/6827 , C12Q1/6806 , G16B30/00 , C12Q1/6869
Abstract: The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
-
公开(公告)号:US20240240258A1
公开(公告)日:2024-07-18
申请号:US18426665
申请日:2024-01-30
Applicant: GUARDANT HEALTH, INC.
Inventor: AmirAli TALASAZ
IPC: C12Q1/6886 , C12N15/10 , C12Q1/6806 , C12Q1/6869 , C12Q1/6874 , G16B30/00 , G16B30/10
CPC classification number: C12Q1/6886 , C12N15/1065 , C12Q1/6806 , C12Q1/6869 , C12Q1/6874 , G16B30/00 , G16B30/10 , C12Q2600/118 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16
Abstract: The present disclosure provides a system and method for the detection of rare mutations and copy number variations in cell free polynucleotides. Generally, the systems and methods comprise sample preparation, or the extraction and isolation of cell free polynucleotide sequences from a bodily fluid; subsequent sequencing of cell free polynucleotides by techniques known in the art; and application of bioinformatics tools to detect rare mutations and copy number variations as compared to a reference. The systems and methods also may contain a database or collection of different rare mutations or copy number variation profiles of different diseases, to be used as additional references in aiding detection of rare mutations, copy number variation profiling or general genetic profiling of a disease.
-
公开(公告)号:US20240153593A1
公开(公告)日:2024-05-09
申请号:US18358388
申请日:2023-07-25
Applicant: GUARDANT HEALTH, INC.
Inventor: Helmy ELTOUKHY , AmirAli TALASAZ
CPC classification number: G16B50/20 , C12Q1/6883 , G16B40/00 , G16B40/20 , G16B40/30 , G16B50/00 , G16H20/00 , G16H50/30 , C12Q1/6886
Abstract: Systems and methods are disclosed for generating a therapeutic response predict or detecting a disease, by: using a genetic analyzer to generate genetic information; receiving into computer memory a training dataset comprising, for each of a plurality of individuals having a disease, (1) genetic information from the individual generated at first time point and (2) treatment response of the individual to one or more therapeutic interventions determined at a second, later, time point; and implementing a machine learning algorithm using the dataset to generate at least one computer implemented classification algorithm, wherein the classification algorithm, based on genetic information from a subject, predicts therapeutic response of the subject to a therapeutic intervention.
-
公开(公告)号:US20240043922A1
公开(公告)日:2024-02-08
申请号:US18491071
申请日:2023-10-20
Applicant: GUARDANT HEALTH, INC.
Inventor: AmirAli TALASAZ , Helmy ELTOUKHY , Stefanie Ann Ward MORTIMER
IPC: C12Q1/6869 , C12Q1/6886
CPC classification number: C12Q1/6869 , C12Q1/6886 , G16B15/00
Abstract: Disclosed herein in are methods and systems for determining genetic variants (e.g., copy number variation) in a polynucleotide sample. A method for determining copy number variations includes tagging double-stranded polynucleotides with duplex tags, sequencing polynucleotides from the sample and estimating total number of polynucleotides mapping to selected genetic loci. The estimate of total number of polynucleotides can involve estimating the number of double-stranded polynucleotides in the original sample for which no sequence reads are generated. This number can be generated using the number of polynucleotides for which reads for both complementary strands are detected and reads for which only one of the two complementary strands is detected.
-
-
-
-
-
-
-
-
-